New gene-editing technology could relieve chronic pain

Written by Jonathan Wilkinson

A research project led by the University of Utah (UT, USA) has reported a new method for reducing chronic pain by editing the epigenome. By modulating genes that reduce tissue- and cell-damaging inflammation, this therapy could hold promise for sufferers of chronic back and joint pain. The research was published in Tissue Engineering, in collaboration with Duke University (NC, USA) and Washington University in St. Louis (MO, USA). Robby Bowles (University of Utah), senior author of the study, commented on the importance of the findings: “This has applications for many inflammatory-driven diseases. It could be applied for arthritis or to...

To view this content, please register now for access

It's completely free